a31907aa1f
- Remove app_v2.py (consolidated into pathways_app.py), fix __init__ import - Add DimSearchTerm.csv, drug_indication_clusters.csv, drug_snomed_mapping_enriched.csv as reference data for SNOMED-based indication matching - Add snomed_indication_mapping_query.sql (source for embedded cluster mapping) - Update DESIGN_SYSTEM.md, RALPH_PROMPT.md, ralph.ps1, uv.lock
12 KiB
12 KiB
| 1 | Drug | Indication | Cluster_ID | Cluster_Description | NICE_TA_Reference |
|---|---|---|---|---|---|
| 2 | ABATACEPT | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA195/TA280/TA375 |
| 3 | ABATACEPT | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA195/TA280/TA375 |
| 4 | ABATACEPT | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA568 |
| 5 | ACALABRUTINIB | Chronic lymphocytic leukaemia | CLL_COD | Chronic lymphocytic leukaemia | TA689 |
| 6 | ADALIMUMAB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA130/TA195/TA375 |
| 7 | ADALIMUMAB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA130/TA195/TA375 |
| 8 | ADALIMUMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA146/TA455 |
| 9 | ADALIMUMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA146/TA455 |
| 10 | ADALIMUMAB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA125/TA199 |
| 11 | ADALIMUMAB | Crohn's disease | CROHNS_COD | Crohn's disease codes | TA187 |
| 12 | ADALIMUMAB | Ulcerative colitis | ULCCOLITIS_COD | Ulcerative colitis codes | TA329 |
| 13 | ADALIMUMAB | Ankylosing spondylitis | ANKSPON_COD | Ankylosing spondylitis codes | TA143/TA383 |
| 14 | AFLIBERCEPT | Diabetic macular oedema | DM_COD | Diabetes mellitus codes | TA346 |
| 15 | AFLIBERCEPT | Diabetic macular oedema | DMTYPE2AUDIT_COD | Type 2 diabetes codes | TA346 |
| 16 | ALIROCUMAB | Hypercholesterolaemia | HYPERCHOL_COD | Hypercholesterolaemia codes | TA393 |
| 17 | APREMILAST | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA419 |
| 18 | APREMILAST | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA419 |
| 19 | APREMILAST | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA433 |
| 20 | ATEZOLIZUMAB | Cancer (various) | CANCER_COD | Cancer codes (various) | TA492/TA520/TA525 |
| 21 | BARICITINIB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA466 |
| 22 | BARICITINIB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA466 |
| 23 | BARICITINIB | Atopic dermatitis | ECZEMA_COD | Atopic dermatitis/eczema codes | TA681 |
| 24 | BEVACIZUMAB | Cancer (various) | CANCER_COD | Cancer codes (various) | TA584/TA666 |
| 25 | BIMEKIZUMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA723 |
| 26 | BIMEKIZUMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA723 |
| 27 | BOTULINUM A TOXIN | Spasticity (various) | SPASTICITY_COD | Spasticity and movement disorder codes | No specific TA |
| 28 | BRODALUMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA511 |
| 29 | BRODALUMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA511 |
| 30 | CERTOLIZUMAB PEGOL | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA375/TA415 |
| 31 | CERTOLIZUMAB PEGOL | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA375/TA415 |
| 32 | CERTOLIZUMAB PEGOL | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA574 |
| 33 | CERTOLIZUMAB PEGOL | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA445 |
| 34 | CERTOLIZUMAB PEGOL | Ankylosing spondylitis | ANKSPON_COD | Ankylosing spondylitis codes | TA383 |
| 35 | DENOSUMAB | Osteoporosis | OSTEO_COD | Osteoporosis codes | TA204 |
| 36 | DENOSUMAB | Bone metastases | CANCER_COD | Cancer codes (bone metastases) | TA265 |
| 37 | DEXAMETHASONE | Diabetic macular oedema | DM_COD | Diabetes mellitus codes | TA349/TA824 |
| 38 | DEXAMETHASONE | Diabetic macular oedema | DMTYPE2AUDIT_COD | Type 2 diabetes codes | TA349/TA824 |
| 39 | DEXAMETHASONE | Multiple myeloma | MM_COD | Multiple myeloma codes | TA311/TA380 |
| 40 | DEXAMETHASONE | Uveitis | UVEITIS_COD | Uveitis codes | TA460 |
| 41 | DIMETHYL FUMARATE | Multiple sclerosis | MS_COD | Multiple sclerosis codes | TA320 |
| 42 | DIMETHYL FUMARATE | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA475 |
| 43 | DOCETAXEL | Cancer (various) | CANCER_COD | Cancer codes (breast/lung/prostate) | TA006/TA030/TA101 |
| 44 | DUPILUMAB | Atopic dermatitis | ECZEMA_COD | Atopic dermatitis/eczema codes | TA534 |
| 45 | DUPILUMAB | Asthma | ASTHMA_COD | Asthma codes | TA751 |
| 46 | ERENUMAB | Migraine | MIGRAINE_COD | Migraine codes | TA682 |
| 47 | ETANERCEPT | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA036/TA130/TA195 |
| 48 | ETANERCEPT | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA036/TA130/TA195 |
| 49 | ETANERCEPT | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA103 |
| 50 | ETANERCEPT | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA103 |
| 51 | ETANERCEPT | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA104/TA199 |
| 52 | ETANERCEPT | Ankylosing spondylitis | ANKSPON_COD | Ankylosing spondylitis codes | TA143/TA383 |
| 53 | EVOLOCUMAB | Hypercholesterolaemia | HYPERCHOL_COD | Hypercholesterolaemia codes | TA394 |
| 54 | FARICIMAB | Diabetic macular oedema | DM_COD | Diabetes mellitus codes | TA799 |
| 55 | FARICIMAB | Diabetic macular oedema | DMTYPE2AUDIT_COD | Type 2 diabetes codes | TA799 |
| 56 | FILGOTINIB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA676 |
| 57 | FILGOTINIB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA676 |
| 58 | FILGOTINIB | Ulcerative colitis | ULCCOLITIS_COD | Ulcerative colitis codes | TA792 |
| 59 | FLUOCINOLONE | Atopic dermatitis | ECZEMA_COD | Atopic dermatitis/eczema codes | TA081 |
| 60 | FLUOCINOLONE | Diabetic macular oedema | DM_COD | Diabetes mellitus codes | TA301 |
| 61 | FLUOCINOLONE | Uveitis | UVEITIS_COD | Uveitis codes | TA590 |
| 62 | FLUOCINOLONE ACETONIDE | Atopic dermatitis | ECZEMA_COD | Atopic dermatitis/eczema codes | TA081 |
| 63 | FLUOCINOLONE ACETONIDE | Diabetic macular oedema | DM_COD | Diabetes mellitus codes | TA301 |
| 64 | FLUOCINOLONE ACETONIDE | Uveitis | UVEITIS_COD | Uveitis codes | TA590 |
| 65 | FREMANEZUMAB | Migraine | MIGRAINE_COD | Migraine codes | TA631/TA764 |
| 66 | GALCANEZUMAB | Migraine | MIGRAINE_COD | Migraine codes | TA659 |
| 67 | GOLIMUMAB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA225/TA375 |
| 68 | GOLIMUMAB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA225/TA375 |
| 69 | GOLIMUMAB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA220 |
| 70 | GOLIMUMAB | Ulcerative colitis | ULCCOLITIS_COD | Ulcerative colitis codes | TA329 |
| 71 | GOLIMUMAB | Ankylosing spondylitis | ANKSPON_COD | Ankylosing spondylitis codes | TA233/TA383 |
| 72 | GUSELKUMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA521 |
| 73 | GUSELKUMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA521 |
| 74 | GUSELKUMAB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA711/TA815 |
| 75 | IDARUCIZUMAB | Anticoagulant reversal | ANTICOAG_COD | Anticoagulation-related codes | No specific TA |
| 76 | IMATINIB | Chronic myeloid leukaemia | CML_COD | Chronic myeloid leukaemia codes | TA050/TA070/TA251 |
| 77 | IMATINIB | Gastrointestinal stromal tumours | GIST_COD | Gastrointestinal stromal tumour codes | TA086/TA326 |
| 78 | IMMUNOGLOBULIN | Immunodeficiency (various) | IMMUNODEF_COD | Primary/secondary immunodeficiency codes | TA481/TA482 |
| 79 | INFLIXIMAB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA036/TA130/TA195 |
| 80 | INFLIXIMAB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA036/TA130/TA195 |
| 81 | INFLIXIMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA134 |
| 82 | INFLIXIMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA134 |
| 83 | INFLIXIMAB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA104/TA199 |
| 84 | INFLIXIMAB | Crohn's disease | CROHNS_COD | Crohn's disease codes | TA040/TA187 |
| 85 | INFLIXIMAB | Ulcerative colitis | ULCCOLITIS_COD | Ulcerative colitis codes | TA163/TA329 |
| 86 | INFLIXIMAB | Ankylosing spondylitis | ANKSPON_COD | Ankylosing spondylitis codes | TA383 |
| 87 | IXEKIZUMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA442 |
| 88 | IXEKIZUMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA442 |
| 89 | IXEKIZUMAB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA537 |
| 90 | IXEKIZUMAB | Ankylosing spondylitis | ANKSPON_COD | Ankylosing spondylitis codes | TA718 |
| 91 | LUCENTIS | Diabetic macular oedema | DM_COD | Diabetes mellitus codes | Biosimilar of ranibizumab |
| 92 | LUCENTIS | Diabetic macular oedema | DMTYPE2AUDIT_COD | Type 2 diabetes codes | Biosimilar of ranibizumab |
| 93 | OBINUTUZUMAB | Chronic lymphocytic leukaemia | CLL_COD | Chronic lymphocytic leukaemia codes | TA343/TA663 |
| 94 | OBINUTUZUMAB | Follicular lymphoma | FL_COD | Follicular lymphoma codes | TA472/TA513/TA629 |
| 95 | OCTREOTIDE | Neuroendocrine tumours | NET_COD | Neuroendocrine tumour codes | No specific TA |
| 96 | OMALIZUMAB | Asthma | ASTHMA_COD | Asthma codes | TA133/TA278 |
| 97 | OMALIZUMAB | Chronic urticaria | URTICARIA_COD | Urticaria codes | TA339 |
| 98 | RANIBIZUMAB | Diabetic macular oedema | DM_COD | Diabetes mellitus codes | TA274 |
| 99 | RANIBIZUMAB | Diabetic macular oedema | DMTYPE2AUDIT_COD | Type 2 diabetes codes | TA274 |
| 100 | REMICADE | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | Brand name for infliximab |
| 101 | REMICADE | Crohn's disease | CROHNS_COD | Crohn's disease codes | Brand name for infliximab |
| 102 | REMICADE | Ulcerative colitis | ULCCOLITIS_COD | Ulcerative colitis codes | Brand name for infliximab |
| 103 | REMICADE | Psoriasis | PSORIASIS_COD | Psoriasis codes | Brand name for infliximab |
| 104 | RILUZOLE | Motor neurone disease | MND_COD | Motor neurone disease codes | TA020 |
| 105 | RISANKIZUMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA596 |
| 106 | RISANKIZUMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA596 |
| 107 | RISANKIZUMAB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA803 |
| 108 | RITUXIMAB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA126/TA195 |
| 109 | RITUXIMAB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA126/TA195 |
| 110 | RITUXIMAB | Non-Hodgkin's lymphoma | NHL_COD | Non-Hodgkin's lymphoma codes | TA037/TA065/TA110 |
| 111 | RITUXIMAB | Chronic lymphocytic leukaemia | CLL_COD | Chronic lymphocytic leukaemia codes | TA174/TA193/TA359 |
| 112 | RITUXIMAB | ANCA-associated vasculitis | VASCULITIS_COD | Vasculitis codes | TA308 |
| 113 | RIXATHON | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | Biosimilar of rituximab |
| 114 | RIXATHON | Non-Hodgkin's lymphoma | NHL_COD | Non-Hodgkin's lymphoma codes | Biosimilar of rituximab |
| 115 | SACITUZUMAB | Triple-negative breast cancer | BREASTCA_COD | Breast cancer codes | TA819 |
| 116 | SARILUMAB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA485 |
| 117 | SARILUMAB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA485 |
| 118 | SECUKINUMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA350/TA734 |
| 119 | SECUKINUMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA350/TA734 |
| 120 | SECUKINUMAB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA445 |
| 121 | SECUKINUMAB | Ankylosing spondylitis | ANKSPON_COD | Ankylosing spondylitis codes | TA407/TA719 |
| 122 | TERIPARATIDE | Osteoporosis | OSTEO_COD | Osteoporosis codes | TA087/TA161 |
| 123 | TILDRAKIZUMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | No TA match found |
| 124 | TILDRAKIZUMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | No TA match found |
| 125 | TOCILIZUMAB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA198/TA247/TA375 |
| 126 | TOCILIZUMAB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA198/TA247/TA375 |
| 127 | TOCILIZUMAB | Juvenile idiopathic arthritis | JIA_COD | Juvenile idiopathic arthritis codes | TA238/TA373 |
| 128 | TOCILIZUMAB | Giant cell arteritis | GCA_COD | Giant cell arteritis codes | TA518 |
| 129 | TOFACITINIB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA480 |
| 130 | TOFACITINIB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA480 |
| 131 | TOFACITINIB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA543 |
| 132 | TOFACITINIB | Ulcerative colitis | ULCCOLITIS_COD | Ulcerative colitis codes | TA547 |
| 133 | UPADACITINIB | Rheumatoid arthritis | RARTH_COD | Rheumatoid arthritis diagnosis codes | TA665/TA744 |
| 134 | UPADACITINIB | Rheumatoid arthritis | C19RARTH_COD | Rheumatoid arthritis disorders (broader) | TA665/TA744 |
| 135 | UPADACITINIB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA768 |
| 136 | UPADACITINIB | Atopic dermatitis | ECZEMA_COD | Atopic dermatitis/eczema codes | TA814 |
| 137 | UPADACITINIB | Ankylosing spondylitis | ANKSPON_COD | Ankylosing spondylitis codes | TA829 |
| 138 | UPADACITINIB | Ulcerative colitis | ULCCOLITIS_COD | Ulcerative colitis codes | TA856 |
| 139 | USTEKINUMAB | Psoriasis | PSORIASIS_COD | Psoriasis codes | TA180/TA455 |
| 140 | USTEKINUMAB | Psoriasis | CUST_CMMS_PSORIASIS | Psoriasis (Cambridge Multimorbidity) | TA180/TA455 |
| 141 | USTEKINUMAB | Psoriatic arthritis | PSORIASIS_COD | Psoriasis codes (for psoriatic arthritis) | TA340 |
| 142 | USTEKINUMAB | Crohn's disease | CROHNS_COD | Crohn's disease codes | TA456 |
| 143 | USTEKINUMAB | Ulcerative colitis | ULCCOLITIS_COD | Ulcerative colitis codes | TA633 |
| 144 | VEDOLIZUMAB | Ulcerative colitis | ULCCOLITIS_COD | Ulcerative colitis codes | TA342 |
| 145 | VEDOLIZUMAB | Crohn's disease | CROHNS_COD | Crohn's disease codes | TA352 |